Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
petercb3 2020. ClearLab Flu+COVID19 Antigen Assay IFU. protocols.io https://dx.doi.org/10.17504/protocols.io.bj8fkrtnCopy Citation Copied
URL: https://dx.doi.org/DOI:10.17504/protocols.io.bj8fkrtn
Authors: petercb3
Group: Coronavirus Method Development Community
Summary: Indication: Qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal aspirate specimens directly or after the aspirate have been added to viral transport media from individuals who are suspected of COVID-19 by their healthcare provider. Emergency use of this test is limited to authorized laboratories and other authorized testing locations.
Affiliations: Chris Baker MD (Aardvark Medical, Inc), Roger Kang (Princeton BioMediTech)
External URL: http://www.clearmynose.com
Version: 1
Publication Date: 2020
Expand AllComing soon.
Source: